Scilex Holding Company Cash and Restricted Cash
Scilex Holding Company (SCLX) had Cash and Restricted Cash of $566.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $566.00K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.35M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.96M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $878.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $566.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $3.35M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $4.96M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $878.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $4.10M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $5.80M 10-Q · filed 2026-05-20 | |
| 2024-12-31 | $3.27M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $8.12M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $9.67M 10-Q · filed 2025-08-13 | |
| 2024-03-31 | $2.77M 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $4.73M 10-K · filed 2026-04-10 | |
| 2023-09-30 | $1.98M 10-Q · filed 2025-01-17 | |
| 2023-06-30 | $35.13M 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $5.07M 10-Q · filed 2024-05-13 | |
| 2022-12-31 | $2.18M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $2.48M 10-Q · filed 2023-11-14 | $34.96K 10-Q · filed 2022-11-04 |
| 2022-06-30 | $6.83M 10-Q · filed 2023-08-11 | $351.27K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $33.57M 10-Q · filed 2023-05-12 | $127.44K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $4.34M 10-K · filed 2024-03-12 | $507.92K 10-Q · filed 2022-05-16 |
| 2021-09-30 | $115.64K 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $257.62K 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $314.92K 10-Q · filed 2022-05-16 | $30.51K 10-Q · filed 2021-08-19 |
| 2020-12-31 | $4.84M 10-K · filed 2024-03-12 | $30.51K 10-Q · filed 2021-11-10 |
| 2020-09-30 | $78.86K 10-Q/A · filed 2021-12-08 | |
| 2019-12-31 | $55.49M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |